Full-Time

Lead System Designer

GE Healthcare

GE Healthcare

1-10 employees

Imaging, monitoring, and healthcare IT solutions

No salary listed

Bengaluru, Karnataka, India

In Person

Bachelor's, Master's

Category
Biology & Biotech (1)
Required Skills
Machine Learning
Computer Networking
Quality Assurance (QA)
Cybersecurity
Risk Management
Data Analysis

Get referred to GE Healthcare

See people who can refer or advise you

Requirements
  • A Bachelor's or Master's degree in Systems Engineering, Electrical Engineering, Computer Engineering, Software Engineering, Biomedical Engineering, or a related engineering discipline is required.
  • A minimum of 5 years of experience in systems engineering, product development, or technical leadership roles for complex products is required.
  • Experience developing regulated products using formal design controls and quality management processes is required.
  • Strong understanding of the medical device development lifecycle, including requirements engineering, architecture, risk management, design verification, validation, and product release, is required.
  • Experience working with multidisciplinary engineering teams across hardware, software, systems, and cloud technologies is required.
  • Knowledge of global medical device standards and regulations, including ISO 13485, ISO 14971, IEC 62304, and IEC 62366, is required.
  • Experience defining and managing system requirements, interfaces, and traceability throughout the development lifecycle is required.
Responsibilities
  • Lead systems engineering activities for next-generation medical devices by defining system requirements, architectures, interfaces, and end-to-end workflows across hardware, software, cloud, and connectivity components.
  • Drive product definition and system design from concept through commercialization, aligning with customer needs, clinical workflows, regulatory requirements, and business objectives.
  • Own requirements management and traceability by translating user, stakeholder, regulatory, and product requirements into verifiable system-level requirements.
  • Lead system architecture and design trade-off analysis across performance, usability, cybersecurity, safety, reliability, scalability, serviceability, cost, and regulatory compliance.
  • Collaborate with software, hardware, cloud, cybersecurity, quality, regulatory, clinical, manufacturing, and product management teams throughout the product development lifecycle.
  • Lead risk management activities in accordance with ISO 14971, including hazard analysis, risk assessment, risk control implementation, and verification of risk mitigations.
  • Ensure compliance with applicable medical device standards and regulations, including ISO 13485, ISO 14971, IEC 62304, IEC 62366, the IEC 60601 series, IEC 81001-5-1, FDA requirements, and MDR requirements.
  • Drive design reviews and technical reviews across all development phases, ensuring readiness for phase gates and regulatory submissions.
  • Partner with Verification and Validation teams to establish comprehensive V&V strategies, ensuring designs are testable and requirements are traceable to objective evidence.
  • Oversee the development and maintenance of Design History Files, system specifications, architecture documents, interface definitions, risk files, and other design-control deliverables.
  • Support regulatory submissions, inspections, audits, and design reviews as the technical systems engineering representative.
  • Lead integration activities involving imaging scanner subsystems, cloud platforms, networking components, artificial intelligence and analytics capabilities, and enterprise healthcare ecosystems.
  • Drive cybersecurity-by-design, privacy-by-design, and secure development practices for connected medical devices and cloud-enabled healthcare solutions.
  • Mentor engineering teams on systems engineering best practices, design controls, risk management, and medical device compliance requirements.
Desired Qualifications
  • Experience developing global medical imaging products such as CT, MRI, PET, Ultrasound, X-Ray, or other diagnostic imaging systems.
  • Experience designing and integrating cloud-connected medical devices, Software as a Medical Device, remote service solutions, or digital healthcare platforms.
  • Understanding of imaging scanner architectures, networking, cybersecurity, edge computing, artificial intelligence and machine learning integration, and healthcare interoperability standards.
  • Experience with FDA, EU MDR, Health Canada, NMPA, PMDA, or other international regulatory frameworks.
  • Familiarity with cybersecurity standards and secure product development practices for medical devices.
  • Experience leading system design for distributed solutions involving imaging scanners, edge devices, cloud infrastructure, web and mobile applications, and enterprise healthcare systems.
  • Strong systems thinking and ability to manage complex cross-functional technical dependencies.
  • Ability to influence technical and business decisions through communication and stakeholder management.
  • Ability to lead architecture discussions, design reviews, and technical decision-making.
  • Strong analytical and problem-solving skills focused on patient safety, product quality, and user experience.
  • Ability to deliver products in a highly regulated environment while balancing technical, clinical, regulatory, and business needs.

GE Healthcare Systems provides medical technologies and digital infrastructure to improve diagnosis, treatment, and monitoring of patients. Its products include imaging systems, mobile diagnostic devices, patient monitoring tools, and healthcare IT software that work together as hardware, software, and services to support hospitals, clinics, and researchers. The company differentiates itself with a large, integrated ecosystem, strong focus on AI analytics, and a global service network backed by substantial R&D investment. Its goal is to improve patient outcomes and the efficiency of healthcare delivery by enabling accurate diagnoses, effective treatments, and scaled operations.

Company Size

1-10

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

1892

Get referred to GE Healthcare

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Photonova Spectra won CE Mark on August 31, 2026, opening Europe sales.
  • Q2 2026 orders rose 11.1%, with 1.15x book-to-bill and record backlog.
  • Vivid cardiovascular ultrasound and ABUS breast screening launches broaden 2026 revenue opportunities.

What critics are saying

  • Patient Care Solutions revenue fell 13.5% in Q2 2026; management is reviewing a sale.
  • Jay Saccaro left in August 2026; William Grogan starts September 14, 2026.
  • If PCS recovery slips into 2027, GE HealthCare becomes a slower-growth imaging vendor.

What makes GE Healthcare unique

  • Photonova Spectra’s Deep Silicon CT differentiates GE HealthCare with photon-counting imaging.
  • GE HealthCare spans imaging, pharma diagnostics, ultrasound, and monitoring across hospital workflows.
  • The July 2026 backlog of $23.9 billion reflects sticky installed-base demand and services.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Relocation Assistance

Company News

Yahoo Finance
Sep 1st, 2026
GE HealthCare secures CE mark for Photonova Spectra photon-counting CT system

GE HealthCare has received CE mark approval for its Photonova Spectra photon-counting computed tomography system, enabling commercial sales in markets recognising CE marking. The clearance follows US Food and Drug Administration approval and Japanese regulatory clearance in March 2026. The system uses GE HealthCare's Deep Silicon detector technology to deliver ultra-high definition spectral and spatial imaging. It processes data volumes up to 50 times greater than conventional CT systems, utilising Nvidia's accelerated computing platform. Clinical collaborations are underway at UZ Brussel in Belgium and Rigshospitalet in Denmark to evaluate the system across cardiology, neurology, oncology and musculoskeletal imaging. The CE mark follows more than $5 billion in innovation investment by GE HealthCare.

Yahoo Finance
Aug 31st, 2026
Vertex Pharmaceuticals shows promise while GE HealthCare and Wells Fargo face challenges

Vertex Pharmaceuticals has emerged as a standout S&P 500 stock, according to StockStory's analysis. The company, which focuses on developing transformative medicines for serious diseases including cystic fibrosis and sickle cell disease, boasts a market capitalisation of $137.3 billion. Meanwhile, StockStory recommends avoiding two large-cap stocks. GE HealthCare, spun off from General Electric in 2023, faces concerns over stagnant organic revenue growth and declining operating margins. The medical equipment provider has a market cap of $32.4 billion. Wells Fargo also made the avoid list. The diversified financial services company, with a $262.2 billion market cap, has seen its net interest margin shrink by 33.6 basis points over two years, suggesting increased competition or declining loan profitability.

Associated Press
Aug 28th, 2026
GE HealthCare launches three new Vivid cardiovascular ultrasound systems for diverse care settings

GE HealthCare has introduced three new cardiovascular ultrasound systems to its Vivid portfolio: Vivid Explorer 1, Vivid Advanced 1, and Vivid Focus 1. The systems were unveiled at the European Society of Cardiology Congress 2026 in Munich, Germany. Each system targets different clinical settings whilst sharing a common technology foundation with the ultra-premium Vivid Pioneer. Vivid Explorer is designed for high-volume echo labs, Vivid Advanced for mid-size hospitals and cardiology practices, and Vivid Focus for everyday cardiac imaging. All three systems use cSound imaging technology and include AI-enabled automation tools to streamline echo workflows. The systems have received CE Mark approval but are awaiting US FDA 510(k) clearance and are not yet available for sale in the United States.

Yahoo Finance
Aug 3rd, 2026
GE HealthCare launches Invenia ABUS Prime and StreamVue for breast cancer screening

GE HealthCare has launched Invenia ABUS Prime and ABUS StreamVue, expanding its breast imaging portfolio with solutions for supplemental screening in women with dense breasts. The Invenia ABUS Prime system has been installed at BeSound in Los Angeles, marking one of the first US installations. ABUS StreamVue is a browser-based reading solution enabling remote exam review across imaging networks. The system received FDA 510(k) clearance and CE Marking. Studies show 40% of women have dense breasts, carrying four to six times higher breast cancer risk. Research indicates mammography may miss one-third of cancers in dense breasts. Invenia ABUS Prime features AI-enabled tools including Scan Quality Assessment and can increase scan speed by up to 40%. The AI Assistant has demonstrated a 33% reduction in reading time.

Yahoo Finance
Jul 29th, 2026
GE HealthCare Q2: Orders up 11%, backlog hits record $23.9B amid Patient Care struggles

GE HealthCare Technologies reported second-quarter results with orders rising 11% year-over-year and backlog reaching a record $23.9 billion. Revenue grew 3.5% organically to $5.3 billion, driven by Advanced Imaging Solutions and Pharmaceutical Diagnostics, which posted organic growth of 5% and 14.6% respectively. Patient Care Solutions remained weak, with revenue falling 13.5% due to component shortages and fulfilment problems. Management is reviewing strategic options for the segment, including a potential sale. The company maintained its full-year outlook of 3–4% organic sales growth, adjusted earnings per share of $4.80–$5.00, and approximately $1.6 billion in free cash flow. CFO Jay Saccaro is departing, with George Newcomb serving as interim CFO.